search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
CONTENTS


Contents 5.


Reaping the benefits of improved clinical study protocols Trilogy’s Dr Julia Forjanic Klapproth on how to create more effective clinical study protocols


8.


Going agile: how it can improve clinical trials David Larwood of Valley Fever Solutions takes an agile approach to clinical trials


12.


Empower your next study with a truly unified system


The lowdown on Axiom Metrics’ e-clinical solutions


14.


Why don’t stem-gene cell clinical trial sponsors count their stem cells? Asymmetrex’s James L. Sherley answers this and other questions


36. 18.


Lessons learned in patient recruitment during the pandemic hy COVID-19 was an accelerated lesson in how to be nimble when it comes to recruitment


20.


Looking back and looking ahead GlobalData Healthcare’s Michael Breen discusses how controlling the coronavirus outbreak affected vaccine programme implementation


24. 26.


Clinical trials are changing, along with support requirements he shifting landscape of clinical trials in a post-pandemic world


Smart packaging, digital labelling, and drone delivery enable the supply chain of the future Merck Research’s Matthew Moyer looks at the evolution of the clinical supply chain


4 | H1 Virtual Events: Review and Summary Handbook 33. 28.


How to efficiently reduce sourcing costs and drug waste N-SIDE’s Rita Meirinhos, and Merck Healthcare’s Fan Feng explain why a collaborative approach combines optimization and processes


31.


Using logistics to get vaccines to patients The pharmaceutical industry has one of the most complex logistical chains in the world, says economic analyst Francisco E Rizzuto


Blockchain and the drug supply chain Frank Leu of BioPharMatrix, discusses a pilot programme for merging two chains to efficiently power forward drug developments


Modern biologics and cell-therapy development through global CMOs A Q&A with Vadim Klyushnichenko from Calibr at Scripps Research Institute


43.


The data science CRO model for outsourcing in clinical trials Denise Lee from Metronomia Clinical Research GmbH, looks at the outsourcing challenges of the future


47.


CRO, CRO, wherefore art thou, CRO? Pulmatrix’s Audrey Rossow on identifying a contract research organization that’s right for you


50.


The journey of extractables and leachables


Aspen Research on solving challenges and expediting product development


53. Suppliers’ Directory


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58